(Q33938840)

English

Adjuvant active specific immunotherapy of stage II and stage III colon cancer with an autologous tumor cell vaccine: first randomized phase III trials show promise

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

30 July 2017

0 references

Adjuvant active specific immunotherapy of stage II and stage III colon cancer with an autologous tumor cell vaccine: first randomized phase III trials show promise (English)

1 reference

Europe PubMed Central

PubMed publication ID

30 July 2017

phase III clinical trial

0 references

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

author name string

Hanna MG Jr

1

1 reference

Europe PubMed Central

PubMed publication ID

30 July 2017

Hoover HC Jr

2

1 reference

Europe PubMed Central

PubMed publication ID

30 July 2017

Vermorken JB

3

1 reference

Europe PubMed Central

PubMed publication ID

30 July 2017

Harris JE

4

1 reference

Europe PubMed Central

PubMed publication ID

30 July 2017

Pinedo HM

5

1 reference

Europe PubMed Central

PubMed publication ID

30 July 2017

language of work or name

0 references

publication date

1 March 2001

1 reference

Europe PubMed Central

PubMed publication ID

30 July 2017

1 reference

Europe PubMed Central

PubMed publication ID

30 July 2017

19

1 reference

Europe PubMed Central

PubMed publication ID

30 July 2017

17-19

1 reference

Europe PubMed Central

PubMed publication ID

30 July 2017

2576-2582

1 reference

Europe PubMed Central

PubMed publication ID

30 July 2017

The tea leaves of small trials

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2800%2900485-0

7 January 2021

based on heuristic

inferred from DOI database lookup

Comparative efficacy of adjuvant chemotherapy in patients with Dukes' B versus Dukes' C colon cancer: results from four National Surgical Adjuvant Breast and Bowel Project adjuvant studies (C-01, C-02, C-03, and C-04)

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2800%2900485-0

7 January 2021

based on heuristic

inferred from DOI database lookup

Active specific immunotherapy for stage II and stage III human colon cancer: a randomised trial

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2800%2900485-0

7 January 2021

based on heuristic

inferred from DOI database lookup

Adjuvant active specific immunotherapy for human colorectal cancer: 6.5-year median follow-up of a phase III prospectively randomized trial

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2800%2900485-0

7 January 2021

based on heuristic

inferred from DOI database lookup

Adjuvant active specific immunotherapy for stage II and III colon cancer with an autologous tumor cell vaccine: Eastern Cooperative Oncology Group Study E5283.

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2800%2900485-0

7 January 2021

based on heuristic

inferred from DOI database lookup

Prolongation of survival in metastatic melanoma after active specific immunotherapy with a new polyvalent melanoma vaccine.

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2800%2900485-0

7 January 2021

based on heuristic

inferred from DOI database lookup

Treatment of metastatic melanoma with an autologous tumor-cell vaccine: clinical and immunologic results in 64 patients.

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2800%2900485-0

7 January 2021

based on heuristic

inferred from DOI database lookup

Active specific immunotherapy in ovarian cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2800%2900485-0

7 January 2021

based on heuristic

inferred from DOI database lookup

Renal cell carcinoma treated by vaccines for active specific immunotherapy: correlation of survival with skin testing by autologous tumor cells

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2800%2900485-0

7 January 2021

based on heuristic

inferred from DOI database lookup

Effects of adjuvant tamoxifen and of cytotoxic therapy on mortality in early breast cancer. An overview of 61 randomized trials among 28,896 women.

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2800%2900485-0

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1016/S0264-410X(00)00485-0

1 reference

Europe PubMed Central

PubMed publication ID

30 July 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

30 July 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q33938840&oldid=1536144512"